Single domain antibodies: promising experimental and therapeutic tools in infection and immunity – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open science
Nanobodies als Hoffnungsträger: Neue Perspektive für Therapie von Knochenmarkkrebs – Innovations Report
Prof. Dr. med. Friedrich Koch-Nolte - Internist Hamburg
Untitled Document
Prof. Dr. med. Friedrich Koch-Nolte in 20251 Hamburg FA für Innere Medizin - ärzte.de | aerzte.de
UKE - Wissenschaftlerprofil - Friedrich Koch-Nolte
Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT – topic of research paper in Biological sciences. Download scholarly article PDF and read for
Friedrich KOCH-NOLTE | Deputy Director | University Medical Center Hamburg - Eppendorf, Hamburg | Institute of Immunology | Research profile
VISION TALK #05: Friedrich Koch-Nolte - Immunologe & Schriftsteller - YouTube
Friedrich Koch-Nolte - Professor, Head, Hamburg, Germany | eMedEvents
Friedrich Koch-Nolte, Laboratory of Molecular Immunology. EuroMAbNet
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
MESSENGER
AWARD: SFB 1328
UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF Humanisierte Schwerekettenantikörper für die Markierung und Tötung CD38-exprimierende
ADP-Ribosylation in Animal Tissues: Structure, Function, and Biology of Mono (ADP-ribosyl) Transferases and Related Enzymes | SpringerLink
The classical pathway triggers pathogenic complement activation in membranous nephropathy | Nature Communications
Friedrich Koch-Nolte, Laboratory of Molecular Immunology. EuroMAbNet
30+ "Friedrich Koch" profiles | LinkedIn
